Newly appointed ScinoPharm Taiwan Ltd (台灣神隆) president Tony Su (蘇崇銘) yesterday said that he would oversee the company’s transition amid immense changes in global markets and supply chains.
“My first responsibility at the company would be to oversee continuation of organizational restructuring and cost management,” Su told an earnings conference.
He said that the global market for generic drugs has been reshuffled by rapid consolidation and the company faces increasing challenges as prices trend lower.
Apart from changing its chief financial and research and development officers, there has not been a major shift in the management team, although key executives would take on additional roles to better align them with the company’s objectives, Su said.
Su was previously with Uni-President Enterprises Corp (UPE, 統一企業), a major investor in ScinoPharm.
ScinoPharm, which makes active pharmaceutical ingredients (APIs), as well as providing contract manufacturing and research services, said that it would begin to see profit contribution from a newly approved generic oncology injection that was developed with US-based Sagent Pharmaceutical Inc.
ScinoPharm said that its generic version of anti-thrombotic drug Fondaparinux in March gained approval from the US Food and Drug Administration and is to begin sales in the US in two to three months time.
The anti-thrombotic drug is also expected to gain market approval from Indian authorities and commence sales there this year, the company said.
This year, ScinoPharm has gained regulatory approval in China to supply generic APIs for a treatment for benign prostatic hyperplasia and a generic oncology injectible for myeloid leukemia in the US.
The company has observed a significant shift in China’s API supply chain as Beijing tightens environmental requirements, ScinoPharm marketing and sales vice president Portia Lin (林靜雯) said.
China has been ordering noncompliant manufacturers to shut down, leading to disruptions in the supply and pricing of chemicals, Lin said.
The company has minimized the disruption by importing from other markets, Lin said, adding that China’s new plant inspection regimen and stricter drug license approvals should help push out low-quality API suppliers.
The company reported that net income in the second quarter dipped 3 percent quarterly to NT$131 million (US$4.27 million), although revenue rose 14 percent to NT$986 million on the back of strong sales of colorectal cancer products. Earnings per share (EPS) were NT$0.17.
In the April-to-June period, gross margin and operating margin were 43 percent and 16 percent respectively, up from 39 percent and 14 percent in the previous period.
Overall, net income in the first half rose 5 percent annually to NT$267 million, or EPS of NT$0.34, while sales gained 4 percent to reach NT$1.85 billion.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
TRANSFORMATION: Taiwan is now home to the largest Google hardware research and development center outside of the US, thanks to the nation’s economic policies President Tsai Ing-wen (蔡英文) yesterday attended an event marking the opening of Google’s second hardware research and development (R&D) office in Taiwan, which was held at New Taipei City’s Banciao District (板橋). This signals Taiwan’s transformation into the world’s largest Google hardware research and development center outside of the US, validating the nation’s economic policy in the past eight years, she said. The “five plus two” innovative industries policy, “six core strategic industries” initiative and infrastructure projects have grown the national industry and established resilient supply chains that withstood the COVID-19 pandemic, Tsai said. Taiwan has improved investment conditions of the domestic economy
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day